Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients

Rafael Sanchez-Salas, Jean de la Rosette, Thomas J. Polascik, Arie Carneiro, Arjun Sivaraman, Xavier Cathelineau, Jochen Walz

Research output: Contribution to journalEditorial

3 Scopus citations

Abstract

The literature on focal therapy is currently insufficient to recommend it as first-line treatment. We need information from both randomised controlled trials and prospective registries for every available energy. That said, important research is under way in this field, and the door should be kept open to an approach that has the potential to offer adequate cancer control with lower morbidity and better post-treatment quality of life in properly selected patients.

Original languageEnglish
Pages (from-to)537-539
Number of pages3
JournalEuropean Urology
Volume74
Issue number5
DOIs
StatePublished - Nov 2018
Externally publishedYes

Fingerprint Dive into the research topics of 'Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients'. Together they form a unique fingerprint.

  • Cite this